CClinicalTrials.gg
Status unknownNCT03729531Updated Jul 8, 2020

Clinical Effect of No-touch Harvesting Technique in OPCABG

An interventional study of Conventional vein harvesting technique and no-touch vein harvesting technique in Coronary Artery Disease and Graft Failure, sponsored by Beijing Anzhen Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2020-07-08.

Sponsored by Beijing Anzhen Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study aims to investigate the clinical effect of the new saphenous vein harvesting technique "No-touch" in off-pump coronary artery bypass grafting(OPCABG), comparing to the conventional technique. Adopting CTA to evaluate the 3 months patency of the graft, we will compare veins harvested using No-touch technique to saphenous veins using conventional open technique.

Read the detailed description

Coronary artery disease(CAD) is a widespread health issue around the world. It is proven that atherosclerosis is a inflammatory disease, and endothelial dysfunction is one of the key factors that initiates the inflammatory response. Accumulating studies indicate that endothelial homeostasis plays a primordial role in the development of atherosclerosis.

Coronary artery bypass grafting(CABG) is the standard treatment of three-vessel or left main coronary artery disease, and its long-term benefits is apparent. Saphenous vein is the most common graft in CABG, however, the long-term patency is only about 50% in one year, as a result, it is urgent to discover a solution to improve the long term potency of vein grafts.

Conventional harvesting technique dissects the perivascular tissue and inject saline to check leakage, which causes damages to the endothelium of the vein, initiating inflammatory response. No-touch technique is a atraumatic, non-distended harvesting technique. According to the criteria, we will randomize the patients into two groups, the conventional and No-touch group, the vein will be used in sequential anastomosis, by comparing the 3 months patency rate assessed by CTA, we aim to compare the clinical outcomes of the two different vein harvesting techniques.

02

Conditions studied

  • Coronary Artery Disease
  • Graft Failure

Keywords

  • Coronary Artery Disease
  • Coronary Artery Bypass Grafting
  • Vein Graft Failure
  • Endothelial dysfunction
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's planned enrollment of 200 is above the median of 124 across 3,436 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Beijing Anzhen Hospital is the lead sponsor of 188 studies on the registry; 100 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients from northern China
  • first time isolated off-pump coronary artery bypass graft
  • echocardiogram show that ejection fraction is over 35%
  • the diameter of saphenous vein ≥ 2mm
  • the vein graft will be used in sequential anastomosis, and the anastomosis sites ≥2
  • be able to sign informed consent form

Exclusion criteria

Exclusion Criteria:

  • patients who need to undergo urgent surgery
  • Severe renal insufficiency(creatinine >200 umol/L)
  • allergic to radiocontrast agent
  • vein is used to isolated anastomosis
  • Combined with malignant tumor or other severe systemic conditions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Conventional

    The perivascular tissue is stripped off when harvesting the vein, and saline will be used to distend the vein to check for leakage.

    Procedure: Conventional vein harvesting technique

  • Experimental
    No-touch

    The vein will be harvested by frequency electrotome and the perivascular tissue will be preserved, the vein will not be distended.

    Procedure: no-touch vein harvesting technique

Interventions

  • ProcedureConventional vein harvesting technique

    Long incision will be used to expose the vein, the perivascular tissue will be dissected carefully by scissors, to check for leakage, the vein will be distended by injecting saline.

  • Procedureno-touch vein harvesting technique

    The vein will be harvested by low-frequency electrotome, about 5mm surrounding tissue will be preserved with the vein, distention should be avoided, the vein will not be cut off until being anastomosed.

06

What researchers measure

Primary outcomes

  1. short-term patency rate of vein grafts

    the patency of vein grafts will be assessed by CTA, the doctors of CT department will be masked, at least 2 doctors will provide their conclusions.when the results is controversial, the third doctor will be asked to review the image and provide another conclusion, the patency will be assessed according all results.

    Time frame: 3 months after surgery

Secondary outcomes

  1. long-term patency rate of vein grafts

    the patency will be assessed by CTA the same as short-term patency

    Time frame: 12 months after surgery

  2. major adverse cardiac and cerebrovascular events(MACCE) rate

    all-cause death, myocardial infarction, stroke,repeat revascularizaiton

    Time frame: 3 months and 12 months after surgery

  3. CCS grade

    the grade of angina wii be assessed according to Canadian Cardiovascular Society standard

    Time frame: 3 months and 12 months after surgery

  4. the healing of the lower leg incision

    the healing of the incision will be divided into primary healing, e.g. less tissue defects, neat wound edges, no infection, adhesion or suture to create a tight wound; delayed healing, which means the wound does not closed within 1 month; infection, the wound does not close after 3 months, or necrotic tissues are seen in the incision.

    Time frame: 3 months and 12 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Beijing Anzhen Hospital, Capital medical university
    Beijing, Beijing 100029, China
    • Ju-bing Zheng, M.D. · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03729531
Lead sponsor
Beijing Anzhen Hospital
Collaborators
Beijing Municipal Administration of Hospitals
Responsible party
Zheng Ju-bing (Clinical investigator, Beijing Anzhen Hospital) — Principal investigator
First posted
Nov 2, 2018
Start date
Dec 21, 2018
Primary completion
Jun 8, 2021 (estimated)
Completion
Jul 1, 2021 (estimated)
Last update
Jul 8, 2020

Study contacts

Ju-bing Zheng, M.D.
Contact
zhengjubing@hotmail.com
86-13683113119
Kui Zhang, M.D.
Contact
86-15001178663
Ju-bing Zheng, M.D.
study director · Beijing Anzhen Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion